Virtus ETF Advisers LLC - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 3 filers reported holding JUNO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$359,000
-43.9%
7,860
-44.9%
0.45%
+423.3%
Q3 2017$640,000
+65.4%
14,261
+10.1%
0.09%
+48.3%
Q2 2017$387,000
+11.5%
12,957
-17.2%
0.06%
-6.5%
Q1 2017$347,000
+30.0%
15,654
+10.6%
0.06%
-22.5%
Q4 2016$267,000
+47.5%
14,153
+135.2%
0.08%
-9.1%
Q3 2016$181,000
-21.6%
6,0170.0%0.09%
-48.5%
Q2 2016$231,000
+13.2%
6,017
+12.4%
0.17%
-39.1%
Q1 2016$204,0005,3530.28%
Other shareholders
JUNO THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Crestline Management, LP 25,948,799$1,055,857,000100.00%
Omega Fund Management, LLC 1,329,512$54,098,00030.46%
SOUND ENERGY PARTNERS, INC. 25,800$1,050,0002.12%
Graticule Asia Macro Advisors LLC 435,205$17,708,0002.06%
BB BIOTECH AG 1,305,000$53,100,0001.68%
Kazazian Asset Management, LLC 13,376$544,0000.69%
Rock Springs Capital Management LP 197,001$8,016,0000.65%
TURNER INVESTMENTS LLC 69,680$2,835,0000.57%
MIZUHO SECURITIES USA LLC 49,600$2,018,0000.52%
Private Capital Advisors, Inc. 27,900$1,135,0000.48%
View complete list of JUNO THERAPEUTICS INC shareholders